Biotech News

USANA Schedules First Quarter 2026 Earnings Release and Conference Call

Usana Health Sciences, Inc. (USNA)Usana Health Sciences, Inc.Earnings

SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2026 results will be released after the close of market on Tuesday, May 5, 2026. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, May 6, 2026 at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://ir.usana.com.

About USANA

USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company and a 100% interest in Rise Wellness. Hiya and Rise Wellness offer a variety of clean-label health products. More information on Hiya can be found at www.hiyahealth.com. More information on Rise Wellness can be found on www.risebar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260415942776/en/

Investor contact:

Andrew Masuda

Investor Relations

(801) 954-7201

[email protected]

Source: USANA Health Sciences, Inc.

Related news

Usana Health Sciences, Inc.

Health and Wellness Platform USANA Health Sciences develops and distributes nutritional, personal-care and wellness products. The company is transitioning from a predominantly direct-selling model toward a broader omnichannel health and wellness platform. Core Nutritional Business USANA’s established business offers supplements and...

Recent company news

Stock data

Close
14.89 USD
Market cap
333.26M USD
Exchange
NYSE
Sector
Biopharma
Location
United States